MSI2 and Alzheimer disease: Western blot analyses of soluble fractions demonstrate significantly increased levels of both MSI1 and MSI2 proteins in AD cases when compared with the controls (p = 0.035 *and p = 0.005 **, respectively) (Fig. 2d).